Public Profile

Deutsche Pharma Holding GmbH

Deutsche Pharma Holding GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany (DE) and operates extensively across Europe and beyond. Founded in the early 2000s, the company has established itself as a leader in the development and distribution of innovative healthcare solutions, focusing on prescription medications and over-the-counter products. With a commitment to quality and efficacy, Deutsche Pharma offers a diverse portfolio that includes specialty pharmaceuticals and generics, catering to various therapeutic areas. The company is recognised for its rigorous research and development processes, ensuring that its products meet the highest standards of safety and effectiveness. Deutsche Pharma Holding GmbH has achieved significant milestones, positioning itself as a trusted name in the market, known for its dedication to improving patient outcomes and advancing healthcare solutions.

DitchCarbon Score

How does Deutsche Pharma Holding GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Deutsche Pharma Holding GmbH's score of 20 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.

76%

Deutsche Pharma Holding GmbH's reported carbon emissions

Deutsche Pharma Holding GmbH currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete data, it is essential to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprints. However, without specific information on Deutsche Pharma Holding GmbH's initiatives or commitments, it is challenging to provide a detailed overview of their climate strategy.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Deutsche Pharma Holding GmbH's primary industry is Real estate services (70), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Deutsche Pharma Holding GmbH is headquartered in DE, which has a rank of medium, indicating medium grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Deutsche Pharma Holding GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers